[1] Torre LA,Bray F, Siegel RL,et al. Global cancer statistics,2012[J].CA Cancer J Clin, 2015,65(2):87-108.[2] 刘险峰,唐 俊.中国高龄老人的社会保障问题初探[J].中国行政管理,2011,6(3):20-23.[3] Jimbo M, Rana GK, Hawley S,et al.What is lacking in current decision aids on cancer screening? [J].CA Cancer J Clin, 2013,63(3):193-214.[4] Balachandra K,Laisupasin P,Dhepakson P,et al.Preliminary clinical evaluation of a protein chip for tumor marker serodiagnosis of various cancers [J].Asian Pac J Allergy Immunol,2003,21(3):171-178.[5] Wingfield SA,Heflin MT.Cancer screening in older adults[J].Clin Geriatr Med, 2016,32(1):17-33.[6] 严海燕,钟日辉,李 竞,等.多肿瘤标志物蛋白芯片在老年人健康筛查中的应用[J].中华流行病学杂志,2011,32(9):924-926.[7] 匡 红,孙 晨,李 静,等.多肿瘤标志物蛋白芯片技术在人群健康体检中的应用[J].国际检验医学杂志,2013,34(9):1074-1076.[8] 陆汉魁,季 红,顾建英,等.多项肿瘤标志物生物芯片检测系统的初步临床应用[J].标记免疫分析与临床,2005,12(4):196-199.[9] 林尤斌.肿瘤标志物蛋白芯片应用于老年人健康筛查的评估分析[J].中国老年学杂志,2013,33(12):2931-2932.[10] 汪广杰,王 东,张 涛,等.血清多种肿瘤标志物联合检测对肺癌的诊断价值[J].重庆医学,2015,44(13):1759-1761.[11] Center MM,Jemal A, Lortet-Tieulent J, et al.International variation in prostate cancer incidence and mortality rates[J].Eur Urol,2012,61(6):1079-1092.[12] Tay KJ, Moul JW, Armstrong AJ.Management of prostate cancer in the elderly [J].Clin Geriatr Med,2016,32(1):113-132.[13] Pomerantz M.Active surveillance:pathologic and clinical variables associated with outcome[J].Surg Pathol Clin,2015,8(4):581-585.[14] 于普林,郑 宏,苏鸿学,等.中国六城市老年人前列腺增生的患病率及相关因素[J].中华流行病学杂志, 2000,21(4):36-39.[15] 邢金春.前列腺癌诊断治疗学[M].北京:人民卫生出版社,2011:65-67.[16] Kravchick S,Peled R,Dorfman D,et al.Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng /ml[J]. Urology,2005,66(3):542-546. |